|
EP0229810B1
(en)
|
1985-07-09 |
1991-10-16 |
Quadrant Bioresources Limited |
Protection of proteins and the like
|
|
US4958257A
(en)
|
1989-03-29 |
1990-09-18 |
Hughes Aircraft Company |
Heat conducting interface for electronic module
|
|
US5945098A
(en)
|
1990-02-01 |
1999-08-31 |
Baxter International Inc. |
Stable intravenously-administrable immune globulin preparation
|
|
IL101007A
(en)
|
1992-02-18 |
1997-08-14 |
Pharmos Ltd |
Dry stable compositions prepared by lyophilization
|
|
WO1993017700A1
(en)
*
|
1992-03-13 |
1993-09-16 |
Beardsley Terry R |
Immune-enhancing agent for therapeutic use in immunocompromised hosts
|
|
JP3510886B2
(ja)
|
1992-06-23 |
2004-03-29 |
ボツリヌム トキシン リサーチ アソシエイト インコーポレイテッド |
ボツリヌスｂ複合体を含有する医薬組成物
|
|
EP1790352B1
(en)
*
|
1993-12-28 |
2008-07-09 |
Allergan, Inc. |
Use of botulinum toxin for the manufacture of a medicament for reducing low back pain
|
|
PT1086702E
(pt)
|
1994-05-09 |
2005-08-31 |
William J Binder |
Neurotoxinas pre-sinapticas para tratamento da dor de cabeca devida a enxaqueca
|
|
US6203794B1
(en)
|
1994-05-31 |
2001-03-20 |
Allergan Sales, Inc. |
Modification of clostridial toxins for use as transport proteins
|
|
US5962637A
(en)
|
1994-06-03 |
1999-10-05 |
Microbiological Research Authority |
Toxin assay
|
|
GB9411138D0
(en)
|
1994-06-03 |
1994-07-27 |
Microbiological Res Authority |
Toxin assay
|
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
|
US5756468A
(en)
|
1994-10-13 |
1998-05-26 |
Wisconsin Alumni Research Foundation |
Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
|
|
US5512547A
(en)
|
1994-10-13 |
1996-04-30 |
Wisconsin Alumni Research Foundation |
Pharmaceutical composition of botulinum neurotoxin and method of preparation
|
|
US5556771A
(en)
|
1995-02-10 |
1996-09-17 |
Gen-Probe Incorporated |
Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
|
|
GB9508204D0
(en)
|
1995-04-21 |
1995-06-07 |
Speywood Lab Ltd |
A novel agent able to modify peripheral afferent function
|
|
AU4746096A
(en)
|
1995-06-06 |
1996-12-24 |
Wisconsin Alumni Research Foundation |
Analogs of botulinum toxin and pharmaceutical compositions o f botulinum toxin
|
|
WO1996039167A1
(en)
|
1995-06-06 |
1996-12-12 |
Pearce L Bruce |
Improved compositions and methods for chemodenervation using neurotoxins
|
|
GB9617671D0
(en)
|
1996-08-23 |
1996-10-02 |
Microbiological Res Authority |
Recombinant toxin fragments
|
|
US8828432B2
(en)
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
|
TW518235B
(en)
|
1997-01-15 |
2003-01-21 |
Akzo Nobel Nv |
A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
|
|
US6777196B2
(en)
|
1997-02-18 |
2004-08-17 |
Genentech, Inc. |
Neurturin receptor
|
|
US9066943B2
(en)
|
1997-07-15 |
2015-06-30 |
The Regents Of The University Of Colorado |
Use of botulinum toxin therapy for treatment of urological neurological conditions
|
|
EP1475099B2
(en)
|
1997-07-15 |
2014-04-09 |
The Regents of the University of Colorado |
Use of botulinum toxin to treat urinary incontinence
|
|
US6638621B2
(en)
|
2000-08-16 |
2003-10-28 |
Lyotropic Therapeutics, Inc. |
Coated particles, methods of making and using
|
|
CN1073626C
(zh)
|
1997-10-18 |
2001-10-24 |
卫生部兰州生物制品研究所 |
A型肉毒结晶毒素的生产工艺及生产该毒素所需的冻干保护液
|
|
SE510813C2
(sv)
|
1997-12-08 |
1999-06-28 |
Arla Ekonomisk Foerening |
Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
|
|
GB9818548D0
(en)
|
1998-08-25 |
1998-10-21 |
Microbiological Res Authority |
Treatment of mucas hypersecretion
|
|
TW574036B
(en)
|
1998-09-11 |
2004-02-01 |
Elan Pharm Inc |
Stable liquid compositions of botulinum toxin
|
|
US20050147690A1
(en)
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
|
PT1031346E
(pt)
|
1999-01-27 |
2002-09-30 |
Idea Ag |
Vacinacao nao invasiva atraves da pele
|
|
EP1031347B1
(en)
|
1999-01-27 |
2002-04-17 |
Idea Ag |
Transnasal transport/immunisation with highly adaptable carriers
|
|
US6776990B2
(en)
|
1999-04-08 |
2004-08-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pancreatitis
|
|
US6573244B1
(en)
|
1999-05-17 |
2003-06-03 |
The United States Of America As Represented By The Secretary Of The Army |
Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
|
|
DE19925739A1
(de)
|
1999-06-07 |
2000-12-21 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Therapeutikum mit einem Botulinum-Neurotoxin
|
|
US6977080B1
(en)
|
1999-08-10 |
2005-12-20 |
Allergan, Inc. |
Intrapericardial botulinum toxin treatment for bradycardia
|
|
AU777556B2
(en)
|
1999-08-25 |
2004-10-21 |
Allergan, Inc. |
Activatable recombinant neurotoxins
|
|
US20030180289A1
(en)
|
1999-09-23 |
2003-09-25 |
Foster Keith Alan |
Inhibition of secretion from non-neuronal cells
|
|
PT1221968E
(pt)
|
1999-10-13 |
2010-04-16 |
Novartis Vaccines & Diagnostic |
Processo de obtenção de respostas imunes celulares de proteínas
|
|
IL149778A0
(en)
|
1999-11-22 |
2002-11-10 |
Universal Preservation Technologies Inc |
Preservation of sensitive biological material
|
|
US6500436B2
(en)
|
2000-01-19 |
2002-12-31 |
Allergan, Inc. |
Clostridial toxin derivatives and methods for treating pain
|
|
US20030118598A1
(en)
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
|
US20030138460A1
(en)
|
2000-02-08 |
2003-07-24 |
Allergan, Inc |
Methods of treating animals with botulinum toxin pharmaceutical compositions
|
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
|
EP1514556B1
(en)
|
2000-02-08 |
2011-08-10 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions
|
|
US8632785B2
(en)
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
|
US20060269575A1
(en)
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
|
US20040033241A1
(en)
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
|
US7491799B2
(en)
|
2000-07-21 |
2009-02-17 |
Allergan, Inc. |
Modified botulinum neurotoxins
|
|
US6653062B1
(en)
|
2000-07-26 |
2003-11-25 |
Wisconsin Alumni Research Foundation |
Preservation and storage medium for biological materials
|
|
US6630330B1
(en)
|
2000-08-02 |
2003-10-07 |
Biopolo S.C.A.R.L. |
Ascorbic acid production from yeast
|
|
EA006759B1
(ru)
|
2000-10-31 |
2006-04-28 |
Бёрингер Ингельхайм Фармасьютиклз, Инк. |
Пероральные лекарственные самоэмульгирующиеся композиции ингибиторов протеазы из класса пиранонов
|
|
US7223577B2
(en)
|
2000-11-17 |
2007-05-29 |
Allergan, Inc. |
Post-translational modifications and Clostridial neurotoxins
|
|
US7273722B2
(en)
|
2000-11-29 |
2007-09-25 |
Allergan, Inc. |
Neurotoxins with enhanced target specificity
|
|
US7255865B2
(en)
|
2000-12-05 |
2007-08-14 |
Allergan, Inc. |
Methods of administering botulinum toxin
|
|
ITUD20010002A1
(it)
|
2001-01-05 |
2002-07-05 |
Univ Degli Studi Udine |
Uso della tossina botulinica per la soluzione di patologie articolari, in particolare della coxartrosi, della epicondilite e della patolo
|
|
US7442686B2
(en)
|
2001-04-12 |
2008-10-28 |
Bioaxone Therapeutique Inc. |
Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
|
|
US20060134140A1
(en)
|
2001-04-12 |
2006-06-22 |
Dana Lasko |
Compositions and methods for treating tumor spreading
|
|
EP1390053A2
(en)
|
2001-04-25 |
2004-02-25 |
Hernan F. Acevedo |
Hcg formulation
|
|
US9157875B2
(en)
|
2001-05-16 |
2015-10-13 |
Benjamin P. Warner |
Drug development and manufacturing
|
|
US8022172B2
(en)
|
2001-08-28 |
2011-09-20 |
Allergan, Inc. |
Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
|
|
US7332567B2
(en)
|
2001-08-28 |
2008-02-19 |
Allergan, Inc. |
Fret protease assays for clostridial toxins
|
|
US7208285B2
(en)
|
2001-08-28 |
2007-04-24 |
Allergan, Inc. |
Fret protease assays for botulinum serotype A/E toxins
|
|
US20030104996A1
(en)
|
2001-08-30 |
2003-06-05 |
Tiansheng Li |
L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US20040161776A1
(en)
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
|
US20050215472A1
(en)
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
MXPA01011542A
(es)
|
2001-11-13 |
2003-05-22 |
Alcon Inc |
Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
|
|
US7491403B2
(en)
|
2002-12-20 |
2009-02-17 |
Botulinum Toxin Research Associates |
Pharmaceutical botulinum toxin compositions
|
|
US7691394B2
(en)
|
2002-05-28 |
2010-04-06 |
Botulinum Toxin Research Associates, Inc. |
High-potency botulinum toxin formulations
|
|
US20040009180A1
(en)
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
US7183066B2
(en)
|
2002-09-27 |
2007-02-27 |
Allergan, Inc. |
Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
|
|
BR0314558A
(pt)
|
2002-10-10 |
2005-08-09 |
Diversa Corp |
Proteases, ácidos nucléicos codificando as mesmas e processos para preparar e usar as mesmas
|
|
US20060140984A1
(en)
|
2002-10-25 |
2006-06-29 |
Foamix Ltd. |
Cosmetic and pharmaceutical foam
|
|
US20040086532A1
(en)
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
|
US20040143213A1
(en)
|
2002-11-12 |
2004-07-22 |
Collegium Pharmaceutical, Inc. |
Inertial drug delivery system
|
|
US20060074014A1
(en)
|
2002-11-18 |
2006-04-06 |
Vicuron Pharmaceuticals Inc. |
Dalbavancin compositions for treatment of bacterial infections
|
|
US20060002862A1
(en)
|
2002-12-17 |
2006-01-05 |
Medimmune Vaccines, Inc. |
High pressure spray-dry of bioactive materials
|
|
GB0300427D0
(en)
|
2003-01-09 |
2003-02-05 |
Univ Strathclyde |
Pharmaceutical composition
|
|
ATE407117T1
(de)
|
2003-01-16 |
2008-09-15 |
Acadia Pharm Inc |
Selektive serotonin 2a/2c inverse rezeptoragonisten als therapeutika für neurodegenerative erkrankungen
|
|
US7758872B1
(en)
|
2003-02-07 |
2010-07-20 |
Eric Finzi |
Method of treating depression
|
|
US20060153876A1
(en)
|
2003-02-24 |
2006-07-13 |
Ira Sanders |
Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease
|
|
WO2004078140A2
(en)
|
2003-03-05 |
2004-09-16 |
Halozyme, Inc. |
SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
US20040214753A1
(en)
|
2003-03-20 |
2004-10-28 |
Britten Nancy Jean |
Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
|
|
US20040204471A1
(en)
|
2003-03-20 |
2004-10-14 |
Pharmacia Corporation |
Treatment and prevention of otic disorders with Cox-2 inhibitors alone or in combination with otic agents
|
|
US9006388B2
(en)
|
2003-03-26 |
2015-04-14 |
Sudhir Paul |
Covalent attachment of ligands to nucleophilic proteins guided by non-covalent
|
|
US7341843B2
(en)
|
2003-04-11 |
2008-03-11 |
Allergan, Inc. |
Botulinum toxin A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
|
|
US7396535B2
(en)
|
2003-04-25 |
2008-07-08 |
Ackerman Alan H |
Therapy for obsessive compulsive head banging
|
|
US7393537B2
(en)
|
2003-04-25 |
2008-07-01 |
Allergan, Inc. |
Botulinum toxin for treatment of obsessive compulsive finger biting disorder
|
|
JP2007521092A
(ja)
|
2003-07-02 |
2007-08-02 |
アルザ・コーポレーシヨン |
小突起アレイの免疫化パッチおよび方法
|
|
DE10333317A1
(de)
|
2003-07-22 |
2005-02-17 |
Biotecon Therapeutics Gmbh |
Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
|
|
US20050042775A1
(en)
|
2003-08-21 |
2005-02-24 |
Nicholas Pomato |
Botulinum antitoxin compositions and methods
|
|
EP1660013A4
(en)
|
2003-08-26 |
2011-07-20 |
Gel Del Technologies Inc |
BIOMATERIAL AND PROTEIN BIOCOACERVATES, METHODS OF MAKING AND USING THEM
|
|
US7148041B2
(en)
|
2003-09-25 |
2006-12-12 |
Allergan, Inc. |
Animal product free media and processes for obtaining a botulinum toxin
|
|
US7160699B2
(en)
|
2003-09-25 |
2007-01-09 |
Allergan, Inc. |
Media for clostridium bacterium and processes for obtaining a clostridial toxin
|
|
US8734810B2
(en)
|
2003-10-29 |
2014-05-27 |
Allergan, Inc. |
Botulinum toxin treatments of neurological and neuropsychiatric disorders
|
|
US8609112B2
(en)
|
2003-10-29 |
2013-12-17 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
|
EP1680178A4
(en)
|
2003-10-31 |
2008-01-02 |
Alza Corp |
SYSTEM AND METHOD FOR THE TRANSDERMAL DISTRIBUTION OF A VACCINE
|
|
KR20070011252A
(ko)
|
2003-11-21 |
2007-01-24 |
알자 코포레이션 |
초음파 보조 경피 백신전달방법 및 시스템
|
|
GB0328060D0
(en)
|
2003-12-04 |
2004-01-07 |
Sod Conseils Rech Applic |
Botulinum toxin treatment
|
|
WO2005055945A2
(en)
|
2003-12-08 |
2005-06-23 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
|
EP2492261B1
(en)
|
2003-12-23 |
2015-02-18 |
Infinity Discovery, Inc. |
Analogs of benzoquinone-containing ansamycins for the treatment of cancer
|
|
CA2552754A1
(en)
|
2004-01-09 |
2005-08-04 |
Alza Corporation |
Frequency assisted transdermal agent delivery method and system
|
|
FR2865131B1
(fr)
|
2004-01-15 |
2007-08-24 |
Gattefosse Ets Sa |
Utilisation d'un extrait d'acmella oleracea pour son effet botox like dans une composition cosmetique anti-rides
|
|
JP4970057B2
(ja)
|
2004-02-24 |
2012-07-04 |
アラーガン、インコーポレイテッド |
ボツリヌス毒素スクリーニングアッセイ
|
|
US20100266638A1
(en)
|
2004-02-26 |
2010-10-21 |
Allergan, Inc. |
Headache treatment method
|
|
US9078892B2
(en)
|
2004-02-26 |
2015-07-14 |
Allergan, Inc. |
Methods for treating pain and for treating a medication overuse disorder
|
|
US20050191321A1
(en)
|
2004-02-26 |
2005-09-01 |
Allergan, Inc. |
Methods for treating headache
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
ES2691498T3
(es)
|
2004-03-03 |
2018-11-27 |
Revance Therapeutics, Inc. |
Aplicación tópica y liberación transdérmica de toxinas botulínicas
|
|
US7674454B2
(en)
|
2004-03-06 |
2010-03-09 |
Innovata Limited |
Enzyme-prodrug therapy for prosthetic joint repair
|
|
US20050214325A1
(en)
|
2004-03-26 |
2005-09-29 |
Vvii Newco 2003, Inc. |
Compositions and methods to increase the effect of a neurotoxin treatment
|
|
MXPA06011429A
(es)
|
2004-04-01 |
2007-04-25 |
Johnson & Johnson |
Aparato y metodo para el suministro transdermico de la vacuna contra la influenza.
|
|
NZ550150A
(en)
|
2004-04-09 |
2009-05-31 |
Wyeth Corp |
Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
|
|
JP2007537783A
(ja)
|
2004-04-13 |
2007-12-27 |
アルザ コーポレイション |
複数のワクチンを経皮送達するための装置及び方法
|
|
ATE380880T1
(de)
|
2004-05-05 |
2007-12-15 |
Pharmaleads |
Mittels botulinumtoxin a (bont/a) erkennbare peptidsubstrate und verwendung
|
|
US7591806B2
(en)
|
2004-05-18 |
2009-09-22 |
Bai Xu |
High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
|
|
EP1747672A4
(en)
|
2004-05-19 |
2010-02-17 |
Alza Corp |
METHOD AND FORMULATION OF TRANSDERMAL DELIVERY OF IMMUNOLOGICALLY ACTIVE AGENTS
|
|
DE102004026152A1
(de)
|
2004-05-28 |
2005-12-15 |
Basf Ag |
Fermentative Herstellung von Feinchemikalien
|
|
JP2008502605A
(ja)
|
2004-06-16 |
2008-01-31 |
スマート ドラッグ システムズ インコーポレイティド |
徐放性ワクチン組成物
|
|
WO2006000229A2
(en)
|
2004-06-28 |
2006-01-05 |
Lifecycle Pharma A/S |
Porous tablets as carriers for liquid formulations
|
|
WO2006011966A1
(en)
|
2004-06-30 |
2006-02-02 |
Allergan, Inc. |
Optimizing expression of active botulinum toxin type e
|
|
US7514088B2
(en)
|
2005-03-15 |
2009-04-07 |
Allergan, Inc. |
Multivalent Clostridial toxin derivatives and methods of their use
|
|
US20060004185A1
(en)
|
2004-07-01 |
2006-01-05 |
Leese Richard A |
Peptide antibiotics and peptide intermediates for their prepartion
|
|
GB2416122A
(en)
|
2004-07-12 |
2006-01-18 |
Ipsen Ltd |
Botulinum neurotoxin composition
|
|
CA2578250C
(en)
|
2004-07-26 |
2013-03-05 |
Merz Pharma Gmbh & Co. Kgaa |
Therapeutic composition with a botulinum neurotoxin
|
|
PL1776137T3
(pl)
|
2004-08-04 |
2015-03-31 |
Ipsen Biopharm Ltd |
Kompozycja farmaceutyczna zawierająca neurotoksynę botulinową
|
|
GB2419527A
(en)
|
2004-10-28 |
2006-05-03 |
Ipsen Ltd |
Pharmaceutical composition containing botulinum neurotoxin
|
|
AU2005271372B2
(en)
|
2004-08-04 |
2012-05-03 |
Allergan, Inc. |
Optimizing expression of active botulinum toxin type A
|
|
EP1982997B1
(en)
|
2004-09-01 |
2012-08-08 |
Allergan, Inc. |
Degradable clostridial toxins
|
|
WO2006029411A2
(en)
|
2004-09-09 |
2006-03-16 |
Yeda Research And Development Co. Ltd. |
Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
|
|
CA2518650A1
(en)
|
2004-09-10 |
2006-03-10 |
Dimitrios Dimitrakoudis |
Clostridium botulinum toxin formulation and method for reducing weight
|
|
US7399607B2
(en)
|
2004-09-22 |
2008-07-15 |
Allergan, Inc. |
Fluorescence polarization assays for determining clostridial toxin activity
|
|
CN101060831B
(zh)
|
2004-10-01 |
2010-06-23 |
拉姆斯科股份有限公司 |
可方便植入的缓释药物组合物
|
|
US20070258992A1
(en)
|
2004-10-06 |
2007-11-08 |
Atassi M Zouhair |
Determining and Reducing Immunoresistance to Botulinum Toxin Therapy Using Botulinum Toxin a Peptides
|
|
US7205018B2
(en)
|
2004-10-07 |
2007-04-17 |
Next Proteins, Inc. |
Carbonated protein drink and method of making
|
|
AU2005301046B2
(en)
|
2004-11-02 |
2012-02-23 |
Chr. Hansen A/S |
Stabilized bacteriophage formulations
|
|
CA2598204C
(en)
|
2004-11-09 |
2015-01-13 |
Board Of Regents, The University Of Texas System |
Stabilized hme composition with small drug particles
|
|
CA2595115C
(en)
|
2004-12-01 |
2014-01-21 |
Health Protection Agency |
Fusion proteins for treating, preventing or ameliorating pain
|
|
CA2588292C
(en)
|
2004-12-01 |
2019-01-15 |
Health Protection Agency |
Non-cytotoxic protein conjugates
|
|
GB0426394D0
(en)
|
2004-12-01 |
2005-01-05 |
Health Prot Agency |
Fusion proteins
|
|
WO2006073410A1
(en)
|
2005-01-03 |
2006-07-13 |
Botulinum Toxin Research Associates, Inc. |
Compositions, methods and devices for preparing less painful botulinum toxin formulations
|
|
US20080220021A1
(en)
|
2005-02-14 |
2008-09-11 |
Pankaj Modi |
Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
|
|
US7838011B2
(en)
|
2005-02-14 |
2010-11-23 |
Pankaj Modi |
Stabilized protein compositions for topical administration and methods of making same
|
|
US7727537B2
(en)
|
2005-02-14 |
2010-06-01 |
Dpm Therapeutics Corp. |
Stabilized compositions for topical administration and methods of making same
|
|
EP1861112A4
(en)
|
2005-03-03 |
2009-07-22 |
Revance Therapeutics Inc |
COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINES
|
|
KR20070116710A
(ko)
|
2005-03-03 |
2007-12-11 |
알러간, 인코포레이티드 |
보툴리눔 독소를 정제하기 위한 동물 산물이 없는 시스템및 프로세스
|
|
JP2008535486A
(ja)
|
2005-03-15 |
2008-09-04 |
アラーガン、インコーポレイテッド |
クロストリジウム毒素標的細胞に対する改変された標的能力を有する修飾クロストリジウム毒素
|
|
WO2006106823A1
(ja)
|
2005-03-31 |
2006-10-12 |
Japan Science And Technology Agency |
分子マーカーを用いた間葉系幹細胞の識別方法及びその利用
|
|
US8124357B2
(en)
|
2005-04-05 |
2012-02-28 |
Allergan, Inc. |
Lipophilic dye-based fret assays for clostridal toxin activity
|
|
US20070029252A1
(en)
|
2005-04-12 |
2007-02-08 |
Dunson James B Jr |
System and process for biomass treatment
|
|
WO2006122123A2
(en)
|
2005-05-09 |
2006-11-16 |
Levin Bruce H |
Methods of alleviating disorders and their associated pain
|
|
US8926991B2
(en)
|
2005-06-14 |
2015-01-06 |
Botulinum Toxin Research Associates, Inc. |
Botulinum toxin and the treatment of primary disorders of mood and affect
|
|
EP2201961B1
(en)
|
2005-06-27 |
2018-01-24 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
US8323666B2
(en)
|
2005-08-01 |
2012-12-04 |
Allergan, Inc. |
Botulinum toxin compositions
|
|
US20070036831A1
(en)
|
2005-08-09 |
2007-02-15 |
Nanobio Corporation |
Nanoemulsion compositions having anti-inflammatory activity
|
|
PT1954308E
(pt)
|
2005-09-16 |
2011-11-03 |
Merial Ltd |
Estabilizadores para vacinas liofilizadas
|
|
JP5134540B2
(ja)
|
2005-09-19 |
2013-01-30 |
アラーガン、インコーポレイテッド |
クロストリジウム毒素活性化クロストリジウム毒素
|
|
US8137677B2
(en)
|
2005-10-06 |
2012-03-20 |
Allergan, Inc. |
Non-protein stabilized clostridial toxin pharmaceutical compositions
|
|
AU2013202329B2
(en)
*
|
2005-10-06 |
2016-04-14 |
Allergan, Inc. |
Non-protein stabilized clostridial toxin pharmaceutical compositions
|
|
CN101175478A
(zh)
*
|
2005-10-06 |
2008-05-07 |
阿勒根公司 |
非蛋白稳定的梭菌毒素药物组合物
|
|
US8168206B1
(en)
|
2005-10-06 |
2012-05-01 |
Allergan, Inc. |
Animal protein-free pharmaceutical compositions
|
|
US20090324647A1
(en)
|
2005-10-11 |
2009-12-31 |
Borodic Gary E |
Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use
|
|
DE102005051789B4
(de)
|
2005-10-28 |
2014-08-07 |
Toxogen Gmbh |
Der Botulinus Neurotoxin A Proteinrezeptor und seine Anwendungen
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
EP1960547A2
(en)
|
2005-12-08 |
2008-08-27 |
Novartis AG |
Effects of inhibitors of fgfr3 on gene transcription
|
|
US20090035354A1
(en)
|
2005-12-30 |
2009-02-05 |
Mor Research Applications Ltd. |
Device and Method for Treating the Anal Sphincter
|
|
JP2009526755A
(ja)
|
2006-01-10 |
2009-07-23 |
ユー， リュイ ジェイ． |
Ｎ−（ホスホノアルキル）−アミノ酸、その誘導体及び組成物及びその利用法
|
|
KR102109867B1
(ko)
|
2006-01-24 |
2020-05-13 |
안선 바이오파르마, 아이엔씨. |
고분자 미소 구체들의 조제를 위한 기술
|
|
US7666912B2
(en)
|
2006-03-23 |
2010-02-23 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for reducing body fat
|
|
EP2105500A1
(de)
|
2008-03-26 |
2009-09-30 |
Pharmazell GmbH |
Neue 12alpha-Hydroxysteroiddehydrogenasen, deren Herstellung und deren Verwendung
|
|
US7473559B2
(en)
|
2006-04-05 |
2009-01-06 |
Charles Lee |
Method for measuring the content of a botulinum toxin in a formulation
|
|
US7309602B2
(en)
|
2006-04-13 |
2007-12-18 |
Ambrozea, Inc. |
Compositions and methods for producing fermentation products and residuals
|
|
ITTO20060282A1
(it)
|
2006-04-14 |
2007-10-15 |
Univ Degli Studi Torino |
Mezzo di coltura e composizione farmaceutica per la rigenerazione del tessuto cartilagineo relativo procedimento relativi usi e prodotti
|
|
JP2009543556A
(ja)
|
2006-07-11 |
2009-12-10 |
アラーガン、インコーポレイテッド |
増強した転位置能力および増強したターゲティング活性を有する改変クロストリジウム毒素
|
|
CA2658260A1
(en)
|
2006-07-11 |
2008-01-17 |
Allergan, Inc. |
Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells
|
|
DE102006035618A1
(de)
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
|
|
US20080044390A1
(en)
|
2006-08-11 |
2008-02-21 |
Xiaowei Jin |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
US9061025B2
(en)
|
2006-08-31 |
2015-06-23 |
Allergan, Inc. |
Methods for selecting headache patients responsive to botulinum toxin therapy
|
|
US8043845B2
(en)
|
2006-09-20 |
2011-10-25 |
American Sterilizer Company |
Sterilization indicator
|
|
EP2511844B1
(en)
|
2006-10-10 |
2015-08-12 |
XRpro Sciences, Inc. |
X-ray microscope
|
|
EP1917971A1
(en)
|
2006-10-27 |
2008-05-07 |
Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) |
Substained release formulations comprising very low molecular weight polymers
|
|
EP1921149A1
(en)
|
2006-11-13 |
2008-05-14 |
AEterna Zentaris GmbH |
Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
|
|
BRPI0719756A2
(pt)
|
2006-12-01 |
2014-01-21 |
Anterios Inc |
Nanopartículas de entidades anfifílicas
|
|
TWI433674B
(zh)
|
2006-12-28 |
2014-04-11 |
Infinity Discovery Inc |
環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
|
|
GB0700523D0
(en)
|
2007-01-11 |
2007-02-21 |
Insense Ltd |
The Stabilisation Of Proteins
|
|
DK2829282T3
(en)
|
2007-03-22 |
2018-01-02 |
Univ Colorado Regents |
Process for preparing an immunologically active adjuvant-linked dried vaccine composition
|
|
WO2008133884A2
(en)
|
2007-04-23 |
2008-11-06 |
Combinatorx, Incorporated |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
EP1985276A1
(en)
|
2007-04-26 |
2008-10-29 |
Merz Pharma GmbH & Co. KGaA |
Treatment of movement disorders by a combined use of a chemodenervating agent and automated movement therapy
|
|
CA2690773C
(en)
|
2007-07-10 |
2013-09-17 |
Medy-Tox, Inc. |
Pharmaceutical liquid composition of botulinum toxin with improved stability
|
|
JP5503543B2
(ja)
|
2007-09-14 |
2014-05-28 |
サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー |
クロストリジウム・ディフィシレトキソイドａおよびｂを含有する薬学的組成物
|
|
US8486467B1
(en)
|
2007-09-20 |
2013-07-16 |
Albert G. Prescott |
Dermal filler and method of using same
|
|
MX350501B
(es)
|
2007-10-12 |
2017-09-07 |
Massachusetts Inst Technology |
Nanotecnologia de vacuna.
|
|
BRPI0819648A2
(pt)
|
2007-11-30 |
2017-05-23 |
Univ California |
sistema de co-cultura, e, métodos de cultura de levedura e produção de halogeneto de metila
|
|
KR20150080038A
(ko)
|
2007-11-30 |
2015-07-08 |
애브비 바이오테크놀로지 리미티드 |
단백질 제형 및 이의 제조방법
|
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
|
US9161970B2
(en)
|
2007-12-12 |
2015-10-20 |
Allergan, Inc. |
Dermal filler
|
|
US9044477B2
(en)
|
2007-12-12 |
2015-06-02 |
Allergan, Inc. |
Botulinum toxin formulation
|
|
JP2011510059A
(ja)
|
2008-01-25 |
2011-03-31 |
ビー アンド ティー エッセ．エッレ．エッレ． |
化粧品分野におけるエステル交換オリーブ油の使用
|
|
EP3346005A1
(en)
|
2008-01-31 |
2018-07-11 |
CureVac AG |
Nucleic acids of formula (i) (nuglxmgnnv)a and derivatives thereof as an immunostimulating agent/adjuvant
|
|
US9107815B2
(en)
|
2008-02-22 |
2015-08-18 |
Allergan, Inc. |
Sustained release poloxamer containing pharmaceutical compositions
|
|
EP4588519A3
(en)
|
2008-03-14 |
2025-10-15 |
Allergan, Inc. |
Immuno-based botulinum toxin serotype a activity assays
|
|
KR101604515B1
(ko)
|
2008-03-14 |
2016-03-17 |
알러간, 인코포레이티드 |
면역-기반 보툴리눔 독소 세로타입 ａ 활성 검정
|
|
EP2271301A4
(en)
|
2008-03-27 |
2014-07-02 |
Agigma Inc |
METHOD AND COMPOSITIONS FOR THE DELIVERY OF FUNDS
|
|
US8617571B2
(en)
|
2008-04-03 |
2013-12-31 |
Allergan, Inc. |
Suture line administration technique using botulinum toxin
|
|
US9119866B2
(en)
|
2008-04-08 |
2015-09-01 |
Huiru Wang |
Glycan-based drugs, therapies and biomarkers
|
|
KR101100866B1
(ko)
|
2008-04-14 |
2012-01-02 |
한국과학기술원 |
게놈 수준에서의 부탄올 생산 미생물의 대사 네트워크 모델 및 이를 이용한 부탄올 생성 미생물의 대사특성분석 및 결실 표적 스크리닝 방법
|
|
NZ606047A
(en)
|
2008-04-30 |
2015-03-27 |
Xyleco Inc |
Processing biomass
|
|
KR20090120222A
(ko)
|
2008-05-19 |
2009-11-24 |
(주)메디톡스 |
식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여클로스트리디움 보툴리눔 독소를 생산하는 방법
|
|
CA2725329C
(en)
|
2008-05-23 |
2013-10-01 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
KR102080429B1
(ko)
|
2008-06-26 |
2020-02-21 |
안테리오스, 인코퍼레이티드 |
경피 운반
|
|
US8697155B2
(en)
|
2008-07-22 |
2014-04-15 |
Mayo Foundation For Medical Education And Research |
Treatment of obesity and related disorders
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
CN103725717A
(zh)
|
2008-10-17 |
2014-04-16 |
焦耳无限科技公司 |
微生物的乙醇生产
|
|
US9072688B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
|
WO2010054406A1
(en)
|
2008-11-10 |
2010-05-14 |
Alnylam Pharmaceuticals, Inc. |
Novel lipids and compositions for the delivery of therapeutics
|
|
CA2745657C
(en)
|
2008-12-04 |
2022-06-21 |
Botulinum Toxin Research Associates, Inc. |
Extended length botulinum toxin formulation for human or mammalian use
|
|
US9498431B2
(en)
|
2008-12-10 |
2016-11-22 |
Jianjian Xu |
Controlled releasing composition
|
|
EP3067049A1
(en)
*
|
2008-12-10 |
2016-09-14 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
|
EP2358760B1
(en)
|
2008-12-19 |
2015-02-18 |
Momenta Pharmaceuticals, Inc. |
Characterization of o-linked glycans
|
|
LT2379104T
(lt)
|
2008-12-31 |
2018-04-10 |
Revance Therapeutics, Inc. |
Injekcinės botulino toksino vaisto formos
|
|
US9744237B2
(en)
|
2009-01-29 |
2017-08-29 |
Kambiz Thomas Moazed |
Method and system for effecting changes in pigmented tissue
|
|
AU2010208046B2
(en)
|
2009-01-29 |
2014-10-02 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
MX340772B
(es)
|
2009-02-19 |
2016-07-26 |
Merz Pharma Gmbh & Co Kgaa |
Medios y metodos para fabricar neurotoxina altamente pura.
|
|
RU2543650C2
(ru)
|
2009-03-13 |
2015-03-10 |
Аллерган, Инк. |
Иммунологические тесты на активность эндопептидаз с измененной нацеленностью
|
|
ES2689703T3
(es)
|
2009-03-13 |
2018-11-15 |
Allergan, Inc. |
Células útiles para ensayos de actividad de serotipo A de toxina botulínica basados en la respuesta inmunológica
|
|
PT2413947T
(pt)
|
2009-04-01 |
2020-05-28 |
Revance Therapeutics Inc |
Métodos e composições para tratar condições de pele associadas à hiper-reatividade vascular
|
|
EP2248518B1
(en)
|
2009-04-17 |
2013-01-16 |
Merz Pharma GmbH & Co. KGaA |
Formulation for stabilizing proteins, peptides or mixtures thereof.
|
|
US20180027833A1
(en)
|
2009-04-24 |
2018-02-01 |
Nestec S.A. |
Shelf-stable fermented dairy products and methods of making same
|
|
JP2012524549A
(ja)
|
2009-04-24 |
2012-10-18 |
ネステク ソシエテ アノニム |
貯蔵安定な発酵乳製品及びその製造方法
|
|
US9539233B2
(en)
|
2009-05-04 |
2017-01-10 |
Aridis Pharmaceuticals Inc. |
Gallium formulation for the treatment and prevention of infectious diseases
|
|
NZ711583A
(en)
|
2009-05-05 |
2017-03-31 |
Arbutus Biopharma Corp |
Lipid compositions
|
|
WO2013170052A1
(en)
|
2012-05-09 |
2013-11-14 |
Sio2 Medical Products, Inc. |
Saccharide protective coating for pharmaceutical package
|
|
KR102066189B1
(ko)
|
2009-06-10 |
2020-01-14 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
WO2010146591A2
(en)
|
2009-06-18 |
2010-12-23 |
Rdd Pharma Ltd. |
Methods and devices for delivery of pharmaceutical agents within orifices of the body
|
|
ES2615281T3
(es)
|
2009-06-24 |
2017-06-06 |
Charles N.S. Soparkar |
Suplementación con cinc para aumentar la capacidad de respuesta al tratamiento con metaloproteasa
|
|
BRPI1015938A2
(pt)
*
|
2009-06-25 |
2016-09-27 |
Revance Therapeutics Inc |
formulações da toxina botulínica livre de albumina
|
|
US20120107431A1
(en)
|
2009-06-30 |
2012-05-03 |
Dong Hyun Kim |
Cosmetic composition containing a rubus coreanus extract for diminishing skin wrinkles
|
|
US9458536B2
(en)
|
2009-07-02 |
2016-10-04 |
Sio2 Medical Products, Inc. |
PECVD coating methods for capped syringes, cartridges and other articles
|
|
US8129139B2
(en)
|
2009-07-13 |
2012-03-06 |
Allergan, Inc. |
Process for obtaining botulinum neurotoxin
|
|
WO2011011796A2
(en)
|
2009-07-24 |
2011-01-27 |
The Regents Of The University Of California |
Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels
|
|
CN102573802A
(zh)
|
2009-08-12 |
2012-07-11 |
希格默伊德药业有限公司 |
包含聚合物基质和油相的免疫调节组合物
|
|
US8821879B2
(en)
|
2009-09-04 |
2014-09-02 |
Xoma Technology Ltd. |
Anti-botulism antibody coformulations
|
|
US20110059079A1
(en)
|
2009-09-04 |
2011-03-10 |
Xoma Technology Ltd. |
Antibody Coformulations
|
|
CN106893744A
(zh)
|
2009-09-14 |
2017-06-27 |
Gs加特克斯公司 |
生物燃料物质及生物化学物质的制备方法
|
|
EP2513321A2
(en)
|
2009-12-15 |
2012-10-24 |
Stratley AG |
Method for recovery of organic components from dilute aqueous solutions
|
|
WO2011075623A1
(en)
|
2009-12-18 |
2011-06-23 |
Latitude Pharmaceuticals, Inc. |
One - phase gel compos ition compri s ing phos pholi pids
|
|
US10471150B2
(en)
|
2010-01-20 |
2019-11-12 |
Urogen Pharma Ltd. |
Material and method for treating internal cavities
|
|
ES2732150T3
(es)
|
2010-01-20 |
2019-11-20 |
Urogen Pharma Ltd |
Material y método para tratar cavidades internas
|
|
WO2011103465A2
(en)
|
2010-02-20 |
2011-08-25 |
Alexey Gennadievich Zdanovsky |
Botulinum neurotoxin antigenic compositions and methods
|
|
GB201004072D0
(en)
|
2010-03-11 |
2010-04-28 |
Turzi Antoine |
Process, tube and device for the preparation of wound healant composition
|
|
US9327105B2
(en)
|
2010-03-26 |
2016-05-03 |
Itrace Biomedical Inc. |
Active transdermal drug delivery system and the method thereof
|
|
US8940308B2
(en)
|
2010-03-30 |
2015-01-27 |
Allergan, Inc. |
Methods for treating depression
|
|
CN106177940A
(zh)
|
2010-05-26 |
2016-12-07 |
西莱克塔生物科技公司 |
含有佐剂的合成纳米载体的剂量选择
|
|
BRPI1002601E2
(pt)
|
2010-06-01 |
2020-06-30 |
Embrapa Pesquisa Agropecuaria |
composição nanoestruturada de uso veterinário para administração de fármacos
|
|
KR101209266B1
(ko)
|
2010-06-30 |
2012-12-06 |
한국과학기술연구원 |
생분해성 및 온도 감응성 폴리포스파젠계 자성 고분자, 그의 제조 방법 및 용도
|
|
WO2012015912A1
(en)
|
2010-07-30 |
2012-02-02 |
Medimmune, Llc |
Method for purifying active polypeptides or immunocojugates
|
|
EP2627318B1
(en)
|
2010-10-12 |
2017-08-16 |
Merz Pharma GmbH & Co. KGaA |
Formulation suitable for stabilizing proteins, which is free of mammalian excipients
|
|
US8685381B2
(en)
|
2010-10-23 |
2014-04-01 |
Joel Schlessinger |
Topical base and active agent-containing compositions, and methods for improving and treating skin
|
|
SG189513A1
(en)
|
2010-10-27 |
2013-05-31 |
Quantibact As |
Capture of target dna and rna by probes comprising intercalator molecules
|
|
CN103314101B
(zh)
|
2010-11-03 |
2016-05-18 |
加利福尼亚大学董事会 |
通过蛋白质生物质发酵的重组微生物的生物燃料和化学生产
|
|
FR2967913A1
(fr)
|
2010-11-29 |
2012-06-01 |
Vetalis |
Composition galenique adaptee a l'administration a un animal non-humain, utilisations de celle-ci et methodes associees
|
|
HRP20171483T1
(hr)
|
2011-01-07 |
2017-12-01 |
Revance Therapeutics, Inc. |
Topikalni pripravak koji se sastoji od botulinskog toksina i boje
|
|
SG10201804552WA
(en)
|
2011-01-24 |
2018-07-30 |
Anterios Inc |
Nanoparticle compositions, formulations thereof, and uses therefor
|
|
EP2675474B1
(en)
|
2011-02-15 |
2019-01-16 |
Vaxiion Therapeutics, LLC |
Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
|
|
AU2012220564A1
(en)
|
2011-02-23 |
2013-08-29 |
Ams Research Corporation |
Drug releasing pelvic treatment system and method
|
|
US20120222979A1
(en)
|
2011-03-04 |
2012-09-06 |
Elwha LLC, a limited liability company of the State of Delaware |
Glassy compositions
|
|
KR101978527B1
(ko)
*
|
2011-03-10 |
2019-09-03 |
엑스에리스 파머수티클스, 인크. |
펩티드 약물의 비경구 주입을 위한 안정한 제형
|
|
CN103458887A
(zh)
|
2011-03-31 |
2013-12-18 |
雀巢产品技术援助有限公司 |
用于增加精氨酸水平的营养组合物及其使用方法
|
|
DK2692350T4
(da)
|
2011-03-31 |
2023-09-04 |
Medy Tox Inc |
Lyofiliseret præparat af botulinumtoksin
|
|
US9512495B2
(en)
|
2011-04-07 |
2016-12-06 |
Virdia, Inc. |
Lignocellulose conversion processes and products
|
|
SG193928A1
(en)
|
2011-04-12 |
2013-11-29 |
Nestec Sa |
Nutritional compositions including branched chain fatty acids for improving gut barrier function
|
|
RU2013151083A
(ru)
|
2011-04-18 |
2015-05-27 |
Нестек С.А. |
ПИТАТЕЛЬНЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ α-ГИДРОКСИИЗОКАПРОНОВУЮ КИСЛОТУ (α-HICA) И ЦИТРУЛЛИН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
|
PT2707031T
(pt)
|
2011-05-08 |
2019-09-05 |
Legochem Biosciences Inc |
Conjugados de proteína e agente ativo e processo para a sua preparação
|
|
US20130309273A1
(en)
|
2012-05-17 |
2013-11-21 |
Kimberly Hassett |
Thermostable Vaccine Compositions and Methods of Preparing Same
|
|
JP6110845B2
(ja)
|
2011-05-17 |
2017-04-05 |
ザ リージェント オブ ザ ユニバーシティー オブ コロラド、ア ボディー コーポレート |
耐熱性ワクチン組成物及びそれを調製する方法
|
|
BR112013032396A2
(pt)
|
2011-06-17 |
2016-11-22 |
Halozyme Inc |
formulações estáveis de aplicações relacionadas à enzima de degradação de ácido hialurônico
|
|
US8586020B2
(en)
|
2011-06-30 |
2013-11-19 |
Korea Institute Of Science And Technology |
Poly(organophosphazene) composition for biomaterials
|
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
|
US20130053792A1
(en)
|
2011-08-24 |
2013-02-28 |
Ablative Solutions, Inc. |
Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation
|
|
KR20130022923A
(ko)
|
2011-08-26 |
2013-03-07 |
삼성전자주식회사 |
가상 시점 합성 예측을 이용한 부호화/복호화 장치 및 부호화/복호화 방법
|
|
WO2013063280A1
(en)
|
2011-10-25 |
2013-05-02 |
Corning Incorporated |
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
|
|
PE20181541A1
(es)
|
2011-10-27 |
2018-09-26 |
Massachusetts Inst Technology |
Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco
|
|
US9283217B2
(en)
|
2011-11-10 |
2016-03-15 |
Allergan, Inc. |
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
|
|
EP2776603B1
(en)
|
2011-11-11 |
2019-03-06 |
SiO2 Medical Products, Inc. |
PASSIVATION, pH PROTECTIVE OR LUBRICITY COATING FOR PHARMACEUTICAL PACKAGE, COATING PROCESS AND APPARATUS
|
|
EP3360428B1
(en)
|
2011-12-15 |
2021-08-04 |
Société des Produits Nestlé S.A. |
Cohesive thin liquids to promote safe swallowing in dysphagic patients
|
|
US20140356340A1
(en)
|
2011-12-15 |
2014-12-04 |
Nestec S.A. |
Extensional viscosity to promote safe swallowing of food boluses
|
|
LT3130347T
(lt)
|
2011-12-30 |
2019-10-25 |
Halozyme Inc |
Ph20 polipeptido variantai, kompozicijos ir jų panaudojimas
|
|
EP2634190A1
(en)
|
2012-03-01 |
2013-09-04 |
Lead Discovery Center GmbH |
Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors
|
|
CN104254612B
(zh)
|
2012-04-26 |
2018-06-01 |
安迪苏法国联合股份有限公司 |
一种2,4-二羟基丁酸的生产方法
|
|
ES2996347T3
(en)
|
2012-06-29 |
2025-02-12 |
Cytosorbents Corp |
Biocompatible sorbent
|
|
US20150297800A1
(en)
|
2012-07-03 |
2015-10-22 |
Sio2 Medical Products, Inc. |
SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS
|
|
WO2014008138A2
(en)
|
2012-07-03 |
2014-01-09 |
Sio2 Medical Products, Inc. |
SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS
|
|
JP6514103B2
(ja)
|
2012-07-06 |
2019-05-15 |
ゲンマブ ビー．ブイ． |
三重変異を有する二量体タンパク質
|
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
|
BR112015001884B1
(pt)
|
2012-07-31 |
2020-12-01 |
Société des Produits Nestlé S.A. |
composição nutricional para promover a saúde musculoesquelética em pacientes com doença inflamatória intestinal (ibd), seu uso, e formulação farmacêutica, formulação nutricional, formulação de alimentação por tubo, suplemento alimentar, alimento funcional ou produto de bebida
|
|
WO2014025663A1
(en)
|
2012-08-05 |
2014-02-13 |
Absci, Llc |
Inducible coexpression system
|
|
WO2015020982A2
(en)
|
2013-08-04 |
2015-02-12 |
Aquavit Pharmaceuticals, Inc. |
Direct application system and method for the delivery of bioactive compositions and formulations
|
|
US10894062B2
(en)
|
2012-08-10 |
2021-01-19 |
Aquavit Pharmaceuticals, Inc. |
Vitamin supplement compositions for injection
|
|
US10980865B2
(en)
|
2012-08-10 |
2021-04-20 |
Aquavit Pharmaceuticals, Inc. |
Direct application system and method for the delivery of bioactive compositions and formulations
|
|
FR2996855B1
(fr)
|
2012-10-16 |
2016-11-11 |
Lesaffre & Cie |
Souches de levures pour la production de biomasse sur un substrat comprenant un sucre en c5, leurs procedes d'obtention et utilisations de la biomasse produite
|
|
MX370929B
(es)
|
2012-10-28 |
2020-01-08 |
Revance Therapeutics Inc |
Composiciones y usos de las mismas para el tratamiento seguro de la rinitis.
|
|
GB201219602D0
(en)
|
2012-10-31 |
2012-12-12 |
Syntaxin Ltd |
Recombinant clostridium botulinum neurotoxins
|
|
CA2880897C
(en)
|
2012-11-21 |
2020-01-14 |
Syntaxin Limited |
Methods for the manufacture of proteolytically processed polypeptides
|
|
WO2014078911A1
(en)
|
2012-11-26 |
2014-05-30 |
Borody Thomas J |
Compositions for the restoration of a fecal microbiota and methods for making and using them
|
|
US10564150B2
(en)
|
2012-12-28 |
2020-02-18 |
Cellestis Limited |
Cell mediated immune response assay
|
|
CA2897606C
(en)
|
2013-01-11 |
2021-05-11 |
Impossible Foods Inc. |
Methods and compositions for consumables
|
|
WO2014124096A1
(en)
|
2013-02-06 |
2014-08-14 |
Perosphere Inc. |
Stable glucagon formulations
|
|
US9650608B2
(en)
|
2013-02-22 |
2017-05-16 |
Medivet America, Llc |
Activating adipose-derived stem cells for transplantation
|
|
US9662450B2
(en)
|
2013-03-01 |
2017-05-30 |
Sio2 Medical Products, Inc. |
Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus
|
|
US9937099B2
(en)
|
2013-03-11 |
2018-04-10 |
Sio2 Medical Products, Inc. |
Trilayer coated pharmaceutical packaging with low oxygen transmission rate
|
|
EP4234753A3
(en)
|
2013-03-11 |
2023-11-01 |
SiO2 Medical Products, Inc. |
Coated packaging
|
|
US10081654B2
(en)
|
2013-03-13 |
2018-09-25 |
President And Fellows Of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
|
EP2968206A4
(en)
|
2013-03-15 |
2016-09-21 |
Nusirt Sciences Inc |
TREATMENT OF PETS WITH SIRTUIN ACTIVATORS
|
|
EP2970389B1
(en)
|
2013-03-15 |
2020-08-19 |
Rhythm Pharmaceuticals, Inc. |
Pharmaceutical compositions
|
|
US9603799B2
(en)
|
2013-03-15 |
2017-03-28 |
Htd Biosystems Inc. |
Liposomal vaccine adjuvants and methods of making and using same
|
|
EP2986140A4
(en)
|
2013-03-15 |
2016-10-19 |
Nusirt Sciences Inc |
COMPOSITIONS, PROCESSES AND KIT FOR TREATMENT OF PETS
|
|
AU2014242565A1
(en)
|
2013-03-26 |
2015-10-15 |
Premier Nutrition Corporation |
Methods for enhancing muscle protein synthesis following concurrent training
|
|
EP2981249A4
(en)
|
2013-04-02 |
2016-11-23 |
Stc Unm |
MESOPOROUS ALAN NANOPARTICLES AS A UNIVERSAL PLATFORM FOR ADSORPTION, PRESENTATION, AND ADMINISTRATION OF ANTIGENS
|
|
US20160073650A1
(en)
|
2013-04-16 |
2016-03-17 |
Nestec S.A. |
Shelf-stable fermented dairy products and methods of making same
|
|
RU2535115C1
(ru)
|
2013-05-15 |
2014-12-10 |
Бости Трейдинг Лтд |
Фармацевтический состав, содержащий нейротоксин ботулина
|
|
WO2014186754A2
(en)
|
2013-05-16 |
2014-11-20 |
Board Of Regents The University Of Texas System |
Dry solid aluminum adjuvant-containing vaccines and related methods thereof
|
|
CN103257233B
(zh)
|
2013-05-31 |
2015-08-05 |
南京祥中生物科技有限公司 |
一种同时可视化检测多种抗生素、非法添加剂及生物毒素的生物芯片及方法
|
|
CN105517434B
(zh)
|
2013-07-02 |
2019-04-09 |
奥斯特利亚诺瓦新加坡私人有限公司 |
一种冷冻干燥包囊细胞的方法、冻干的包囊细胞、含有冻干的包囊细胞的组合物及这种细胞和组合物的用途
|
|
US11753656B2
(en)
|
2013-08-15 |
2023-09-12 |
Lallemand Hungary Liquidity Management Llc |
Methods for the improvement of product yield and production in a microorganism through glycerol recycling
|
|
US9480731B2
(en)
*
|
2013-12-12 |
2016-11-01 |
Medy-Tox, Inc. |
Long lasting effect of new botulinum toxin formulations
|
|
CN103705913A
(zh)
*
|
2013-12-27 |
2014-04-09 |
柳州市工人医院 |
A型肉毒毒素在制备治疗雷诺综合征药物的应用
|
|
BR112016015573A2
(pt)
|
2014-01-02 |
2017-10-03 |
Trelys Inc |
Composições e métodos para produção biológica de aminoácidos em micro-organismos hidrogenotróficos
|
|
US10260111B1
(en)
|
2014-01-20 |
2019-04-16 |
Brett Eric Etchebarne |
Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
|
|
US10071103B2
(en)
|
2014-01-29 |
2018-09-11 |
Vyome Biosciennces Pvt. Ltd. |
Treatments for resistant acne
|
|
CN106132430A
(zh)
|
2014-02-06 |
2016-11-16 |
Xeris药物公司 |
稳定肽制剂及其制备方法
|
|
CA2938790A1
(fr)
|
2014-02-14 |
2015-08-20 |
Vesale Pharma Sa |
Composition comprenant du bifidobacterium animalis ssp. lactis
|
|
TW201613864A
(en)
|
2014-02-20 |
2016-04-16 |
Takeda Pharmaceutical |
Novel compounds
|
|
US9389162B2
(en)
|
2014-04-10 |
2016-07-12 |
City University Of Hong Kong |
Detection of analyte using coffee-ring effect
|
|
RS58440B1
(sr)
|
2014-04-11 |
2019-04-30 |
Medimmune Llc |
Konjugovana jedinjenja koja sadrže cistein-projektovana antitela
|
|
CA2945951A1
(en)
|
2014-04-15 |
2015-10-22 |
Industrial Microbes, Inc. |
Synthetic methanotrophic microorganisms
|
|
GB201407525D0
(en)
|
2014-04-29 |
2014-06-11 |
Syntaxin Ltd |
Manufacture of recombinant clostridium botulinum neurotoxins
|
|
EP3760186A1
(en)
*
|
2014-04-30 |
2021-01-06 |
Allergan, Inc. |
Formulations of biologics for intravesical instillation
|
|
EP3149187B1
(en)
|
2014-05-30 |
2020-04-29 |
Braskem S.A. |
Modified microorganisms comprising an optimized system for oligosaccharide utilization and methods of using same
|
|
US11484580B2
(en)
|
2014-07-18 |
2022-11-01 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
US9901627B2
(en)
|
2014-07-18 |
2018-02-27 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
AU2015292550A1
(en)
|
2014-07-23 |
2017-02-16 |
Robert Schwartz |
Precision chemical ablation and treatment of tissues
|
|
CA2957790A1
(en)
|
2014-08-13 |
2016-02-18 |
Akeso Biomedical, Inc. |
Antimicrobial compounds and compositions, and uses thereof
|
|
US10913736B2
(en)
|
2014-08-22 |
2021-02-09 |
University Of Washington |
Specific inhibitors of methionyl-tRNA synthetase
|
|
WO2016048689A1
(en)
|
2014-09-23 |
2016-03-31 |
Avidas Pharmaceuticals Llc |
Delivery and induction of therapeutic agents and uses thereof
|
|
US10410749B2
(en)
|
2014-10-21 |
2019-09-10 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
|
|
US10357157B2
(en)
|
2014-10-21 |
2019-07-23 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
|
|
US10325685B2
(en)
|
2014-10-21 |
2019-06-18 |
uBiome, Inc. |
Method and system for characterizing diet-related conditions
|
|
US9710606B2
(en)
|
2014-10-21 |
2017-07-18 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
|
|
US10381112B2
(en)
|
2014-10-21 |
2019-08-13 |
uBiome, Inc. |
Method and system for characterizing allergy-related conditions associated with microorganisms
|
|
US10366793B2
(en)
|
2014-10-21 |
2019-07-30 |
uBiome, Inc. |
Method and system for characterizing microorganism-related conditions
|
|
US9107906B1
(en)
|
2014-10-28 |
2015-08-18 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
|
BR102014028009B1
(pt)
|
2014-11-10 |
2023-04-18 |
Universidade Federal De Pelotas |
Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos
|
|
GB201421013D0
(en)
|
2014-11-26 |
2015-01-07 |
Turzi Antoine |
New standardizations & medical devices for the preparation of platelet rich plasma (PRP) or bone marrow centrate (BMC)
|
|
EP3226849A4
(en)
|
2014-12-03 |
2018-05-09 |
Velicept Therapeutics, Inc. |
Compositions and methods of using modified release solabegron for lower urinary tract symptoms
|
|
CN107427548A
(zh)
|
2014-12-08 |
2017-12-01 |
Jjsk 研发私人有限公司 |
载体分子组合物及相关方法
|
|
CA2972233A1
(en)
|
2014-12-26 |
2016-06-30 |
Conjugon, Inc. |
Methods and compositions for growth, storage, and use of bacterial preparations for wound and surface treatments
|
|
US11040022B2
(en)
|
2015-02-05 |
2021-06-22 |
William H. Cross, III |
Compositions and methods for pain relief
|
|
BR112017019349A2
(pt)
|
2015-03-11 |
2018-06-05 |
Melinta Therapeutics Inc |
compostos antimicrobianos e métodos de fabricação e uso dos mesmos
|
|
SG11201707506WA
(en)
|
2015-03-13 |
2017-10-30 |
Evolve Biosystems Inc |
Compositions that metabolize or sequester free sugar monomers and uses thereof
|
|
IL294055A
(en)
|
2015-03-20 |
2022-08-01 |
Childrens Nat Medical Ct |
Generating virus or other antigen-specific t cells from a naive t cell population
|
|
WO2016164705A1
(en)
|
2015-04-10 |
2016-10-13 |
Omar Abdel-Rahman Ali |
Immune cell trapping devices and methods for making and using the same
|
|
MX2017013562A
(es)
|
2015-04-23 |
2018-05-28 |
Kaleido Biosciences Inc |
Reguladores de microbioma y usos relacionados de los mismos.
|
|
WO2016191545A1
(en)
|
2015-05-26 |
2016-12-01 |
Advaxis, Inc. |
Personalized delivery vector-based immunotherapy and uses thereof
|
|
CN108024563A
(zh)
|
2015-08-11 |
2018-05-11 |
艾索生物医药公司 |
提高家畜中重量增加的生物膜抑制组合物
|
|
EP3337490A4
(en)
|
2015-08-20 |
2019-07-24 |
Genomatica, Inc. |
COMPOSITIONS AND MULTIPLEX SYSTEMS FOR COUPLED CELL-FREE TRANSCRIPTION TRANSLATION AND PROTEIN SYNTHESIS AND METHOD FOR USE THEREOF
|
|
WO2017051254A1
(en)
|
2015-09-25 |
2017-03-30 |
Legochem Biosciences, Inc. |
Compositions and methods related to anti-egfr antibody drug conjugates
|
|
EP3359085A4
(en)
|
2015-10-12 |
2019-09-18 |
Toth, Landy |
CONTROLLED AND PRECISE TREATMENT OF HEARTWOVEN
|
|
KR102847348B1
(ko)
|
2015-11-25 |
2025-08-19 |
주식회사 리가켐바이오사이언스 |
펩타이드 그룹을 포함하는 접합체 및 이와 관련된 제조방법
|
|
US11173214B2
(en)
|
2015-11-25 |
2021-11-16 |
Legochem Biosciences, Inc. |
Antibody-drug conjugates comprising branched linkers and methods related thereto
|
|
SI3380124T1
(sl)
|
2015-11-25 |
2024-10-30 |
Legochem Biosciences, Inc. |
Konjugati, ki obsegajo samožrtvujoče skupine in z njimi povezani postopki
|
|
CN105363018B
(zh)
|
2015-12-02 |
2019-08-30 |
南京碧迪可医药科技有限公司 |
一种硫肽环素的新用途
|
|
WO2017123367A1
(en)
|
2016-01-11 |
2017-07-20 |
Siemens Aktiengesellschaft |
Program randomization for cyber-attack resilient control in programmable logic controllers
|
|
MX2018008906A
(es)
|
2016-01-21 |
2019-01-10 |
Selux Diagnostics Inc |
Metodos para pruebas rapidas de susceptibilidad antimicrobiana.
|
|
US20170209553A1
(en)
|
2016-01-22 |
2017-07-27 |
Transderm, Inc. |
Delivery of botulinum with microneedle arrays
|
|
US11268124B2
(en)
|
2016-01-25 |
2022-03-08 |
Bio-Rad Europe Gmbh |
Digital microbiology
|
|
US11771752B2
(en)
|
2016-03-09 |
2023-10-03 |
Prime Bio, Inc. |
Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
|
|
WO2017161091A1
(en)
|
2016-03-16 |
2017-09-21 |
Spogen Biotech Inc. |
Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes
|
|
CA3016922A1
(en)
|
2016-03-16 |
2017-09-21 |
Spogen Biotech Inc. |
Fusion proteins, recombinant bacteria, and exosporium fragments for animal health and aquaculture
|
|
US20170290778A1
(en)
|
2016-04-12 |
2017-10-12 |
Illustris Pharmaceuticals, Inc. |
Compositions for topical application of compounds
|
|
WO2017179775A1
(en)
|
2016-04-12 |
2017-10-19 |
Hugel Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
CN109152803B
(zh)
|
2016-04-25 |
2022-09-23 |
普梭梅根公司 |
用于表征与皮肤相关的病症的方法和系统
|
|
KR102399451B1
(ko)
|
2016-05-27 |
2022-05-23 |
입센 바이오팜 리미티드 |
트립토판 또는 타이로신으로 안정화된 액체 신경독 제형
|
|
WO2017210700A1
(en)
|
2016-06-03 |
2017-12-07 |
Velicept Therapeutics, Inc. |
Compositions and methods of using modified release solabegron for lower urinary tract symptoms
|
|
TWI737742B
(zh)
|
2016-06-22 |
2021-09-01 |
德商梅茲製藥有限兩合公司 |
肉毒桿菌毒素的預填充式注射器系統、具有其之套組以及其之使用
|
|
EP3481851B1
(en)
|
2016-07-08 |
2021-11-24 |
Metabolic Explorer |
Method for the fermentative production of molecules of interest by microorganisms comprising genes coding sugar phosphotransferase system (pts)
|
|
WO2018038301A1
(en)
|
2016-08-26 |
2018-03-01 |
Hugel Inc. |
Stabilized liquid formulation of botulinum toxin and preparation method thereof
|
|
KR102552356B1
(ko)
|
2016-08-26 |
2023-07-07 |
에스케이 조인트 벤처스 |
보툴리눔 독소의 효능 증대를 위한 생분해성 폴리머 제제
|
|
WO2018038585A1
(ko)
|
2016-08-26 |
2018-03-01 |
주식회사 에이비바이오 |
보툴리눔 독소 및 안정화제를 포함하는 액상 제형 및 이의 제조방법
|
|
US11554108B2
(en)
|
2016-08-29 |
2023-01-17 |
Xeropedix, Inc. |
Methods and compositions for treating cutaneous fungal infections
|
|
RU2762607C2
(ru)
|
2016-09-13 |
2021-12-21 |
Аллерган, Инк. |
Стабилизированные небелковые композиции клостридиального токсина
|
|
KR102463881B1
(ko)
|
2016-10-04 |
2022-11-07 |
(주)메디톡스 |
보툴리눔 독소 함유 용액으로부터 보툴리눔 독소를 분리하는 방법
|
|
CA3040614A1
(en)
|
2016-10-26 |
2018-05-03 |
Oxy Solutions As |
Formulations
|
|
WO2018083692A1
(en)
|
2016-11-01 |
2018-05-11 |
Tamar Levin |
Novel methods for modulating protein expression in microorganisms
|
|
CN110099682B
(zh)
|
2016-11-14 |
2023-03-31 |
杭州多禧生物科技有限公司 |
偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用
|
|
US20180147357A1
(en)
|
2016-11-29 |
2018-05-31 |
Amir Marashi |
Delivery method for preparation and administration of pharmaceutical compositions
|
|
US11040090B2
(en)
|
2016-12-08 |
2021-06-22 |
Prime Bio, Inc |
Botulinum neurotoxin compositions
|
|
WO2018112138A1
(en)
|
2016-12-15 |
2018-06-21 |
Anavi Goffer Sharon |
Treatment of mental, movement and behavioral disorders
|
|
WO2018112419A1
(en)
|
2016-12-15 |
2018-06-21 |
uBiome, Inc. |
Method and system for characterizing diet-related conditions
|
|
US20190343139A1
(en)
|
2016-12-27 |
2019-11-14 |
IMB Inc. |
Processing human milk for generating compositions of fortified human milk products
|
|
CN108322936B
(zh)
|
2017-01-16 |
2023-06-02 |
中兴通讯股份有限公司 |
数据重传的方法及装置
|
|
US20190345436A1
(en)
|
2017-01-17 |
2019-11-14 |
White Dog Labs, Inc. |
Proteinic biomass preparation comprising a non-native organism of the clostridia class
|
|
EP3570856A2
(en)
|
2017-01-18 |
2019-11-27 |
Evelo Biosciences, Inc. |
Methods of treating cancer
|
|
KR101744900B1
(ko)
|
2017-01-20 |
2017-06-08 |
주식회사 대웅 |
보툴리눔 독소를 포함하는 안정한 액상 조성물
|
|
KR101776659B1
(ko)
|
2017-02-27 |
2017-09-11 |
주식회사 쿼드메디슨 |
마이크로 니들 및 이의 제조방법
|
|
WO2018175899A1
(en)
|
2017-03-24 |
2018-09-27 |
The Regents Of The University Of Colorado, A Body Corporate |
Targeted nanogels for urinary bladder therapies
|
|
WO2018195097A1
(en)
|
2017-04-17 |
2018-10-25 |
The Regents Of The University Of California |
Engineered commensal bacteria and methods of use
|
|
JOP20190245A1
(ar)
|
2017-04-20 |
2019-10-15 |
Novartis Ag |
أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط
|
|
EP3622289B1
(de)
|
2017-05-11 |
2023-08-23 |
Immundiagnostik AG |
Verfahren und testbesteck zur quantitativen bestimmung von biomarkern in fäkalproben
|
|
CN110913868A
(zh)
|
2017-05-24 |
2020-03-24 |
Atgc 股份有限公司 |
用于治疗足痛疾病的包括肉毒杆菌毒素和透明质酸的药物组合物以及使用其治疗足痛疾病的方法
|
|
US10912823B2
(en)
|
2017-05-31 |
2021-02-09 |
Allergan, Inc. |
Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
|
|
FR3067928B1
(fr)
|
2017-06-23 |
2020-02-28 |
Fondation Mediterranee Infection |
Procede de conservation d'un echantillon de bacteries
|
|
EP3644971A4
(en)
|
2017-06-26 |
2021-03-31 |
Bonti, Inc. |
CLOSTRIDIAL NEUROTOXIN FORMULATIONS AND USE
|
|
BR112019028301A2
(pt)
|
2017-07-05 |
2020-07-14 |
Evelo Biosciences, Inc. |
composições e métodos para tratar câncer com o uso de bifidobacterium animalis ssp. lactis
|
|
SG11202001335UA
(en)
|
2017-08-14 |
2020-03-30 |
Psomagen Inc |
Disease-associated microbiome characterization process
|
|
US12161703B2
(en)
|
2017-08-28 |
2024-12-10 |
Revance Therapeutics, Inc. |
Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disorders
|
|
EP3675883A4
(en)
|
2017-08-30 |
2021-05-12 |
Aobiome LLC |
MICROORGANISMS OXIDIZING AMMONIA FOR THE TREATMENT OF BUTTERFLY ERYTHEMA, ATHLETE'S FOOT, CONTACT DERMATITIS, SWEAT AND BODY ODORS
|
|
JP7369690B2
(ja)
|
2017-09-08 |
2023-10-26 |
エヴェロ バイオサイエンシズ，インコーポレーテッド |
細菌の細胞外小胞
|
|
US10849960B2
(en)
|
2017-09-08 |
2020-12-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovarian cancer
|
|
CA3075270A1
(en)
|
2017-09-08 |
2019-03-14 |
Evelo Biosciences, Inc. |
Extracellular vesicles from prevotella
|
|
KR20200064112A
(ko)
|
2017-10-03 |
2020-06-05 |
크리티테크, 인크. |
암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달
|
|
US10525111B2
(en)
|
2017-10-12 |
2020-01-07 |
Hugel, Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
WO2019075452A1
(en)
|
2017-10-13 |
2019-04-18 |
Evelo Biosciences, Inc. |
IDENTIFICATION OF BACTERIA FOR CANCER THERAPY
|
|
CA3082696A1
(en)
|
2017-11-13 |
2019-05-16 |
Extremochem, Lda. |
Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules
|
|
JP2021502964A
(ja)
|
2017-11-14 |
2021-02-04 |
エヴェロ バイオサイエンシズ，インコーポレーテッド |
ブラウティア（Ｂｌａｕｔｉａ）株を使用して疾患を処置するための組成物及び方法
|
|
EP3713420A4
(en)
|
2017-11-22 |
2021-08-25 |
Aobiome LLC |
TOPICAL USE AND DELIVERY OF AMMONIA COXIDIZING MICRO-ORGANISMS
|
|
EP3716768A4
(en)
|
2017-11-22 |
2021-08-25 |
Aobiome LLC |
TOPICAL USE AND ADMINISTRATION OF MICROORGANISMS OXIDIZING AMMONIA
|
|
CA3083953A1
(en)
|
2017-12-11 |
2019-06-20 |
Board Of Regents, The University Of Texas System |
Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
|
|
CN108205008B
(zh)
|
2017-12-28 |
2020-04-21 |
深圳大学 |
一种基于有机光电化学晶体管的毒素传感器及其制备方法
|
|
CA3087778A1
(en)
|
2018-01-07 |
2019-07-11 |
Avraham Amir |
High-load microneedles and compositions for skin augmentation
|
|
AU2019212338B2
(en)
|
2018-01-24 |
2024-07-11 |
Omnigen Research, Llc |
Bacillus combination for administration to animals
|
|
WO2019152667A1
(en)
|
2018-01-31 |
2019-08-08 |
Evelo Biosciences, Inc. |
Compositions and methods for treating immune disorders using lachnospiraceae bacteria
|
|
CN112118849A
(zh)
|
2018-02-06 |
2020-12-22 |
瑞珍实验室 |
交联透明质酸及与prp/bmc的组合
|
|
BR112020015639A2
(pt)
|
2018-02-06 |
2021-03-30 |
Evelo Biosciences, Inc. |
Composições e métodos para o tratamento de câncer e distúrbios imunológicos usando bactérias veillonella
|
|
KR102063475B1
(ko)
|
2018-02-22 |
2020-01-09 |
주식회사 에이비바이오 |
보툴리눔 독소, 안정화제, 및 국소마취제를 포함하는 액상 제형 및 이의 제조방법
|
|
US20210076724A1
(en)
|
2018-02-28 |
2021-03-18 |
C-Lecta Gmbh |
Enzymatic in-situ fortification of food with functional carbohydrates
|
|
WO2019178055A1
(en)
|
2018-03-12 |
2019-09-19 |
Evelo Biosciences, Inc. |
Extracellular vesicles from burkholderia
|
|
EP3766529A4
(en)
|
2018-03-14 |
2022-03-23 |
Beacon Medcare (HK) Limited |
Composition for purification of biofluids
|
|
WO2019178487A2
(en)
|
2018-03-15 |
2019-09-19 |
Evelo Biosciences, Inc. |
Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae
|
|
WO2019178490A1
(en)
|
2018-03-15 |
2019-09-19 |
Evelo Biosciences, Inc. |
Compositions and methods for treating cancer and inflammation using klebsiella oxytoca
|
|
EP3764988A4
(en)
|
2018-03-15 |
2022-04-20 |
Adepthera LLC |
GEL-FORMING POLYPEPTIDES
|
|
WO2019178494A1
(en)
|
2018-03-15 |
2019-09-19 |
Evelo Biosciences, Inc. |
Compositions and methods for treating cancer and inflammation using tyzzerella nexilis
|
|
US20190321427A1
(en)
|
2018-04-18 |
2019-10-24 |
G&S Laboratories, Inc. |
Compositions to Treat Anal Fissures
|
|
EP3787668B1
(en)
|
2018-05-03 |
2023-10-25 |
Crigasseni AG |
Probiotic bacterial strains producing antimicrobial proteins and compositions comprising these for use in the treatment of clostridium difficile infection
|
|
WO2019226599A1
(en)
|
2018-05-22 |
2019-11-28 |
Alkalidx, Inc. |
Diagnostics and treatments of anesthetic insensitive subjects
|
|
US11464858B2
(en)
|
2018-06-23 |
2022-10-11 |
University Of Wyoming |
Magnetic nanoparticle delivery system for pain therapy
|
|
CA3112394A1
(en)
|
2018-09-13 |
2020-03-19 |
Allergan, Inc. |
Clostridial toxin - hyaluronic acid compositions
|